Forkhead Box Protein C2 Promotes Epithelial-Mesenchymal Transition, Migration and Invasion in Cisplatin-Resistant Human Ovarian Cancer Cell Line (SKOV3/CDDP)
Author(s) -
Chanjuan Li,
Hongjuan Ding,
Jing Tian,
Lili Wu,
Yun Wang,
Xing Yuan,
Min Chen
Publication year - 2016
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000447818
Subject(s) - gene knockdown , epithelial–mesenchymal transition , small hairpin rna , cancer research , downregulation and upregulation , cisplatin , ovarian cancer , cell culture , cell migration , chemistry , protein kinase b , cell growth , matrigel , cell , biology , microbiology and biotechnology , cancer , signal transduction , angiogenesis , biochemistry , genetics , chemotherapy , gene
Forkhead Box Protein C2 (FOXC2) has been reported to be overexpressed in a variety of human cancers. However, it is unclear whether FOXC2 regulates epithelial-mesenchymal transition (EMT) in CDDP-resistant ovarian cancer cells. The aim of this study is to investigate the effects of FOXC2 on EMT and invasive characteristics of CDDP-resistant ovarian cancer cells and the underlying molecular mechanism.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom